NEOGEN \u2014 Recent Activity

Neogen Chemicals Ltd (BOM:542665) Q3 2026 Earnings Call Highlights: Strategic Growth Amidst ...

Neogen Chemicals Ltd (BOM:542665) reports robust revenue growth and strategic advancements despite facing operational headwinds in Q3 2026.

Click to open →

How Recent Earnings And Guidance Are Shaping The Neogen Chemicals (NSEI:NEOGEN) Narrative

Neogen Chemicals’ latest price target update keeps the model fair value unchanged at ₹1,847, even as small shifts in the discount rate and future assumptions fine tune how much weight the market might put on coming cash flows. The new narrative reflects a push and pull between more confident guidance after revenue and EBITDA came in ahead of expectations, and the reminder from some analysts that one strong quarter does not automatically reset the longer term story. As you read on, keep an eye...

Click to open →

How A Reset Price Target Is Reframing The Story For Neogen Chemicals (NSEI:NEOGEN)

Neogen Chemicals is back in focus after a reset in its price target, reflecting a fresh look at what the market is currently willing to pay for the stock. This change is tied directly to an updated narrative around the business, including how investors are thinking about its opportunities and risks today. Read on to see what is driving that changing story and how you can keep on top of future updates to the Neogen Chemicals narrative. Analyst Price Targets don't always capture the full story...

Click to open →

How Recent Developments Are Rewriting The Neogen Chemicals Investment Story

Neogen Chemicals' fair value estimate has inched up from roughly ₹1,807 per share to about ₹1,812 per share, supported by a slightly higher discount rate of around 14.36% that reflects a modestly elevated risk and return expectation. This fine tuned revision mirrors a market narrative in which strong growth visibility and a scalable product portfolio are increasingly acknowledged, even as analysts remain mindful of execution and valuation risks. Stay tuned to see how you can track these...

Click to open →

How Recent Developments Are Shaping the Neogen Chemicals Investment Story

Neogen Chemicals’ stock narrative has seen little movement, with the consensus analyst price target remaining unchanged at ₹1,806.57. This reflects stable expectations from the market. The steady outlook is attributed to the company’s reliable revenue growth and proven track record in the specialty chemicals sector, while ongoing market competition and potential industry headwinds provide some offset. Stay tuned to discover how you can track these evolving market perspectives and stay...

Click to open →

Neogen Chemicals Ltd (BOM:542665) Q2 2026 Earnings Call Highlights: Strategic Growth Amid ...

Neogen Chemicals Ltd (BOM:542665) reports robust revenue growth and strategic advancements despite facing operational hurdles and increased costs.

Click to open →

Looking at the Narrative for Neogen Chemicals as Analyst Views and Valuation Shift

The consensus analyst price target for Neogen Chemicals has recently declined from ₹2,062.83 to ₹1,806.57, reflecting new perspectives on the company's outlook. This shift comes as revenue growth projections have softened and the discount rate has edged higher, highlighting both evolving opportunities and emerging risks in the business environment. Stay tuned to discover how you can keep on top of these changing views as Neogen Chemicals' story unfolds. Stay updated as the Fair Value for...

Click to open →